VIVUS Inc, based in Menlo Park, CA, is a pharmaceutical company dedicated to improving the quality of life for patients with serious medical conditions and life-limiting diseases. With expertise in clinical development and commercialization, VIVUS focuses on addressing therapeutic needs in areas such as obesity, pulmonary arterial hypertension (PAH), and exocrine pancreatic insufficiency (EPI).
Their growing portfolio includes PANCREAZE, a pancreatic enzyme replacement therapy that effectively manages EPI, a condition characterized by a deficiency in pancreatic enzymes leading to chronic diarrhea, weight loss, and malnutrition. Committed to patient care, VIVUS strives to develop innovative solutions to help patients suffering from these chronic diseases.
Generated from the website